As the U.S. market navigates a volatile landscape marked by geopolitical tensions and an impending Federal Reserve rate decision, key indices like the Dow Jones and S&P 500 have seen modest gains, with tech stocks showing resilience amid uncertainty. In such a dynamic environment, identifying high-growth tech stocks requires careful consideration of their adaptability to economic shifts and potential for innovation in response to evolving global challenges.
|
Name |
Revenue Growth |
Earnings Growth |
Growth Rating |
|---|---|---|---|
|
Super Micro Computer |
26.38% |
39.09% |
★★★★★★ |
|
Mereo BioPharma Group |
53.63% |
66.57% |
★★★★★★ |
|
Alvotech |
29.03% |
53.53% |
★★★★★★ |
|
Ardelyx |
20.78% |
59.46% |
★★★★★★ |
|
TG Therapeutics |
26.46% |
38.75% |
★★★★★★ |
|
AVITA Medical |
27.36% |
60.93% |
★★★★★★ |
|
Alnylam Pharmaceuticals |
23.63% |
60.71% |
★★★★★★ |
|
Alkami Technology |
20.54% |
76.67% |
★★★★★★ |
|
Ascendis Pharma |
35.07% |
59.92% |
★★★★★★ |
|
Lumentum Holdings |
22.99% |
103.97% |
★★★★★★ |
Click here to see the full list of 231 stocks from our US High Growth Tech and AI Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: ACADIA Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes medicines for central nervous system disorders and rare diseases in the United States, with a market capitalization of approximately $3.71 billion.
Operations: ACADIA Pharmaceuticals focuses on developing and commercializing innovative medicines for central nervous system disorders and rare diseases, generating approximately $996.28 million in revenue from these activities.
ACADIA Pharmaceuticals has demonstrated resilience and strategic foresight in its operations, evidenced by a recent legal victory that affirmed the validity of its NUPLAZID patent, securing its market position against competitors. This follows a robust first quarter in 2025 with revenues climbing to $244.32 million from $205.83 million year-over-year, and net income increasing to $18.99 million. The firm’s commitment to innovation is underscored by significant R&D investments aimed at expanding its rare disease portfolio, aligning with industry trends towards specialized healthcare solutions. Moreover, the appointment of Allyson McMillan-Youngblood as Senior Vice President highlights a strategic emphasis on leadership within the rare disease sector, potentially catalyzing future growth and operational excellence in this high-stakes arena.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Ciena Corporation is a network technology company that offers hardware, software, and services to network operators across multiple regions globally, with a market cap of approximately $10.43 billion.
Operations: Ciena generates revenue primarily from its Networking Platforms segment, contributing $3.25 billion, followed by Global Services at $551.93 million. The Platform Software and Services segment adds $363.38 million, while Blue Planet Automation Software and Services brings in $103.23 million.
Ciena’s recent executive shifts, including the appointment of Marc D. Graff as CFO, underscore a strategic realignment poised to enhance its financial acumen amidst dynamic market conditions. This move coincides with a robust share repurchase program where Ciena bought back 1.54 million shares for $109.35 million, reflecting confidence in its operational stability and future prospects. Additionally, the company has raised its fiscal 2025 revenue growth forecast to about 14%, signaling strong demand across its offerings despite a fluctuating geopolitical landscape. These developments are pivotal as Ciena continues to innovate in high-capacity network solutions, evidenced by successful trials of advanced optical technologies that promise enhanced data transmission capabilities essential for next-gen AI and cloud applications.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Sea Limited is a consumer internet company with operations in Southeast Asia, Latin America, and internationally, boasting a market cap of approximately $93.65 billion.
Operations: Sea Limited generates revenue primarily from e-commerce, which accounts for $13.19 billion, followed by digital financial services at $2.66 billion and digital entertainment at $1.95 billion. The company operates across multiple regions including Southeast Asia and Latin America, providing a diverse range of consumer internet services.
Sea Limited’s recent financial performance reveals a significant turnaround, with Q1 2025 revenue soaring to $4.84 billion from $3.73 billion in the previous year, and net income shifting from a loss of $23.66 million to a profit of $403.05 million. This robust growth is underscored by an earnings surge of 2134.1% over the past year, vastly outpacing the Entertainment industry’s average decline of 3.6%. Additionally, Sea is poised for continued expansion with expected annual earnings growth at an impressive rate of 30.2%, well above the US market forecast of 14.5%. These figures not only demonstrate Sea’s recovery but also its potential to outperform in a competitive sector, supported by strong fundamentals and effective strategic maneuvers.
-
Unlock more gems! Our US High Growth Tech and AI Stocks screener has unearthed 228 more companies for you to explore.Click here to unveil our expertly curated list of 231 US High Growth Tech and AI Stocks.
-
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
-
Discover a world of investment opportunities with Simply Wall St’s free app and access unparalleled stock analysis across all markets.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ACAD CIEN and SE.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com